>>Signaling Pathways>> Endocrinology and Hormones>> Androgen Receptor>>ORM-15341

ORM-15341

Catalog No.GC32402

ORM-15341은 전장 hAR과 안드로겐 반응성 루시퍼라제 리포터 유전자 구조를 안정적으로 발현하는 AR-HEK293 세포에서 transactivation assays에 의해 나타난 바와 같이 IC50 값이 38nM인 인간 AR(hAR)에 대한 강력하고 완전한 길항제입니다.

Products are for research use only. Not for human use. We do not sell to patients.

ORM-15341 Chemical Structure

Cas No.: 1297537-33-7

Size 가격 재고 수량
10mM (in 1mL DMSO)
US$69.00
재고 있음
5mg
US$63.00
재고 있음
10mg
US$108.00
재고 있음
50mg
US$405.00
재고 있음
100mg
US$378.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

ORM-15341 is a potent and full antagonist for human AR (hAR) with IC50 values of 38 nM as shown by transactivation assays in AR-HEK293 cells stably expressing full-length hAR and an androgen-responsive luciferase reporter gene construct.IC50 value: 38 nMTarget: androgen receptorin vitro: In competitive AR binding assays, the inhibition constant (Ki) values of ORM-15341 was 8 nM. ORM-15341 functions as a full antagonist for all tested mutant ARs , with IC50 of 25, 51, 700, and 1160 nM for wtAR, AR(F876L), AR(T877A), and AR(W741L).

[1]. Moilanen AM, et al. Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms toandrogen signaling-directed prostate cancer therapies. Sci Rep. 2015 Jul 3;5:12007. doi: 10.1038/srep12007. [2]. Toermaekangas Olli, et al. Preparation of heteroaryl carboxamides as androgen receptor modulators. From PCT Int. Appl. (2012), WO 2012143599 A1 20121026.

리뷰

Review for ORM-15341

Average Rating: 5 ★★★★★ (Based on Reviews and 8 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for ORM-15341

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.